Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae

被引:75
作者
Nahm, MH
Olander, JV
Magyarlaki, M
机构
[1] WASHINGTON UNIV, ST LOUIS, MO USA
[2] UNIV PECS, SCH MED, DEPT DERMATOL, PECS, HUNGARY
关键词
D O I
10.1086/514093
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Opsonophagocytic capacity and concentrations of antibodies to the capsular polysaccharide (PS) of Streptococcus pneumoniae serotypes 6A, 6B, 19F, and 19A were determined for sera from adults immunized with 14- and 23-valent S. pneumoniae capsular PS vaccines. The concentration of anticapsular PS antibodies strongly correlated (r = .72 to r = .91) with the opsonophagocytic activities. However, 10%-20% of serum samples display strikingly less opsonophagocytic activity for the crossreactive serotypes than expected on the basis of their antibody concentrations to the cross-reactive serotypes. From 1 poorly opsonic serum sample, kappa and lambda fractions of anti-6B antibodies were purified by affinity chromatography. kappa (but not lambda) type antibody was found to have less opsonophagocytic capacity than expected. Thus, ELISA measurements of antibody responses to pneumococcal capsular PSs may not be reflective of opsonophagocytic function of the antibody.
引用
收藏
页码:698 / 703
页数:6
相关论文
共 27 条
[1]   EMERGENCE OF DRUG-RESISTANT PNEUMOCOCCAL INFECTIONS IN THE UNITED-STATES [J].
BREIMAN, RF ;
BUTLER, JC ;
TENOVER, FC ;
ELLIOTT, JA ;
FACKLAM, RR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (23) :1831-1835
[2]   STRONG ASSOCIATION BETWEEN CAPSULAR TYPE AND VIRULENCE FOR MICE AMONG HUMAN ISOLATES OF STREPTOCOCCUS-PNEUMONIAE [J].
BRILES, DE ;
CRAIN, MJ ;
GRAY, BM ;
FORMAN, C ;
YOTHER, J .
INFECTION AND IMMUNITY, 1992, 60 (01) :111-116
[3]   THE EFFECTS OF IDIOTYPE ON THE ABILITY OF IGG1 ANTI-PHOSPHORYLCHOLINE ANTIBODIES TO PROTECT MICE FROM FATAL INFECTION WITH STREPTOCOCCUS-PNEUMONIAE [J].
BRILES, DE ;
FORMAN, C ;
HUDAK, S ;
CLAFLIN, JL .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1984, 14 (11) :1027-1030
[4]   PNEUMOCOCCAL POLYSACCHARIDE VACCINE EFFICACY - AN EVALUATION OF CURRENT RECOMMENDATIONS [J].
BUTLER, JC ;
BREIMAN, RF ;
CAMPBELL, JF ;
LIPMAN, HB ;
BROOME, CV ;
FACKLAM, RR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (15) :1826-1831
[5]  
FEDSON DS, 1988, VACCINES, P271
[6]  
GRAY BM, 1990, PEDIATRICS, V85, P694
[7]   6 NEWLY RECOGNIZED TYPES OF STREPTOCOCCUS-PNEUMONIAE [J].
HENRICHSEN, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (10) :2759-2762
[8]  
KIYOTAKI M, 1987, J IMMUNOL, V138, P4150
[9]   SOURCES OF LOW-MOLECULAR-WEIGHT HOST FACTORS THAT PHENOTYPICALLY INCREASE THE RESISTANCE OF HEMOPHILUS-INFLUENZAE TYPE B TO BACTERIOLYSIS - NON-IDENTITY WITH A FACTOR ACTIVE IN GONOCOCCI [J].
KURATANA, M ;
INZANA, TJ ;
ANDERSON, P .
MICROBIAL PATHOGENESIS, 1989, 7 (01) :73-77
[10]   Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children - A randomized controlled trial [J].
Lieberman, JM ;
Chiu, SS ;
Wong, VK ;
Partridge, S ;
Chang, SJ ;
Chiu, CY ;
Gheesling, LL ;
Carlone, GM ;
Ward, JI .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (19) :1499-1503